Global leaders in life sciences and nonclinical drug development, Envigo (Huntingdon, UK) and LabCorp (NC, USA), have signed an innovative agreement in a bid to expand nonclinical drug development capabilities and create an independent research models provider.
Read time: 1 min
Citoxlab Group (Évreux, France) has announced it will acquire Solvo Biotechnology (Budaörs, Hungary) securing its position as a leader among the top five non-clinical CROs.
CiToxLab North America has purchased a new facility, which will focus on bioanalysis and biomarker services in Montreal, Canada.
Konica Minolta acquires the US-based pharmaceutical research company Invicro, which specializes in imaging services and software for research and drug development.